alexa Editor - Taosheng Huang | Molecular Diagnostic laboratory at Cin | 24340

Journal of Neuro-Ophthalmology Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Taosheng Huang

Taosheng Huang
Director
Cincinnati Children's Hospital Medical Center (CCHMC) Cincinnati
China.

Biography

Dr. Taosheng Huang is a physician-scientist, currently he is a professor with tenure in Human Genetics, Director, Program of Mitochondrial Medicine. Director of the Molecular Diagnostic laboratory at Cincinnati Children's Hospital Medical Center (CCHMC). Before he moved to CCHMC 2012, he was was an associate professor with tenure in Pediatrics, Developmental and Cell Biology, and Pathology at University of California, Irvine.  He was also the director for the MitoMed Molecular Diagnostic laboratory and Director of the Cardiovascular Genetic Clinic.In 2001, Dr. Huang moved to the University of California, Irvine as an independent investigator.During this time, Dr. Huang’s group was the first to link TBX3 and cancer.  They also found that TBX3 plays a very important role in human embryonic stem cell differentiation.  Currently, this project is funded by NIH R01 and a R01 supplement.  To develop a therapy for genetic disease, Dr. Huang’s lab has also actively pursued the Drosophila model for human genetic diseases. They have created a Drosophila optic atrophy model and identified two distinctive pathways that cause cell loss by mutation of the OPA1 gene.In 2012, Dr. Huang joined Cincinnati Children's Hospital Medical Center (CCHMC) to direct the program of Mitochondrial Medicine

He was appointed member of the special committee for Yusheng Yuyou of People’s Republic of China and advisory board member to Chinese Ministry of Health for targeted therapy. Moreover, he recently became a principal investigator for birth defect control program of Chinese Ministry of Health and a Steering Committee member for Standardized Residency and Fellowship Training. Steering Committee Member of Society of Precision Medicine on Birth Defects, China International Exchange and Promotive Association for Medical and Health Care (CPAM) and the medical expert for Chinese Organization for Rare Disorders, a Steering Committee member for Chinese Association of Genetic Counselors.  Dr. Huang serves for the editorial board of 15 scientific journals and has published over 90 scientific papers in a variety topics.

Research Interest

Clinically, Dr. Huang is interested in genetics of mitochondrial diseases, genetic syndromes with congenital cardiac defects, pharmacogenomics, prenatal screening and prenatal diagnosis and new born screening. He has been actively engaged in the exchange program between the United States and China.  Dr. Huang previously served as VP of New England Area and the medical director of the American Chinese Medical Association.  He has visited China on a regular basis, greatly impacting the health policy there. 

Certificate

Certificate
Leave Your Message 24x7
Top